Global Recombinant Human Keratin Market Research Report 2024

Publication ID:

PB509246666

Publication Date:

September 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Recombinant Human Keratin is human keratin produced by genetic recombinant technology. This protein is expressed in the laboratory by genetically modified cells (such as E. coli or yeast). Keratin is a structural protein naturally present in human skin, hair and nails, with high strength and elasticity. Recombinant human keratin is widely used in skin care products, hair care products, medical treatment and tissue engineering to repair, strengthen and protect damaged tissues due to its high biocompatibility with the human body.
The global Recombinant Human Keratin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Recombinant Human Keratin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Recombinant Human Keratin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Recombinant Human Keratin in Immunoblotting is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Recombinant Human Keratin include Thermo Fisher Scientific(Invitrogen), ABCAM, Novus Biologicals, PROGEN, CUSABIO, Prospec, Biomatik, Creative Diagnostics, Signalway Antibody, enQuire BioReagents, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Keratin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Keratin.
The Recombinant Human Keratin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Keratin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Keratin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific(Invitrogen)
ABCAM
Novus Biologicals
PROGEN
CUSABIO
Prospec
Biomatik
Creative Diagnostics
Signalway Antibody
enQuire BioReagents
Segment by Type
Purity: <90%
Purity: 鈮�90%
Segment by Application
Immunoblotting
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Human Keratin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Human Keratin Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Purity: <90%
1.2.3 Purity: 鈮�90%
1.3 Market by Application
1.3.1 Global Recombinant Human Keratin Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunoblotting
1.3.3 Enzyme-Linked Immunosorbent Assay
1.3.4 Immunohistochemistry
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Human Keratin Market Perspective (2019-2030)
2.2 Global Recombinant Human Keratin Growth Trends by Region
2.2.1 Global Recombinant Human Keratin Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Recombinant Human Keratin Historic Market Size by Region (2019-2024)
2.2.3 Recombinant Human Keratin Forecasted Market Size by Region (2025-2030)
2.3 Recombinant Human Keratin Market Dynamics
2.3.1 Recombinant Human Keratin Industry Trends
2.3.2 Recombinant Human Keratin Market Drivers
2.3.3 Recombinant Human Keratin Market Challenges
2.3.4 Recombinant Human Keratin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human Keratin Players by Revenue
3.1.1 Global Top Recombinant Human Keratin Players by Revenue (2019-2024)
3.1.2 Global Recombinant Human Keratin Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Human Keratin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Recombinant Human Keratin Revenue
3.4 Global Recombinant Human Keratin Market Concentration Ratio
3.4.1 Global Recombinant Human Keratin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Human Keratin Revenue in 2023
3.5 Global Key Players of Recombinant Human Keratin Head office and Area Served
3.6 Global Key Players of Recombinant Human Keratin, Product and Application
3.7 Global Key Players of Recombinant Human Keratin, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Human Keratin Breakdown Data by Type
4.1 Global Recombinant Human Keratin Historic Market Size by Type (2019-2024)
4.2 Global Recombinant Human Keratin Forecasted Market Size by Type (2025-2030)
5 Recombinant Human Keratin Breakdown Data by Application
5.1 Global Recombinant Human Keratin Historic Market Size by Application (2019-2024)
5.2 Global Recombinant Human Keratin Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Recombinant Human Keratin Market Size (2019-2030)
6.2 North America Recombinant Human Keratin Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Recombinant Human Keratin Market Size by Country (2019-2024)
6.4 North America Recombinant Human Keratin Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Human Keratin Market Size (2019-2030)
7.2 Europe Recombinant Human Keratin Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Recombinant Human Keratin Market Size by Country (2019-2024)
7.4 Europe Recombinant Human Keratin Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Human Keratin Market Size (2019-2030)
8.2 Asia-Pacific Recombinant Human Keratin Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Recombinant Human Keratin Market Size by Region (2019-2024)
8.4 Asia-Pacific Recombinant Human Keratin Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Human Keratin Market Size (2019-2030)
9.2 Latin America Recombinant Human Keratin Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Recombinant Human Keratin Market Size by Country (2019-2024)
9.4 Latin America Recombinant Human Keratin Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Human Keratin Market Size (2019-2030)
10.2 Middle East & Africa Recombinant Human Keratin Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Recombinant Human Keratin Market Size by Country (2019-2024)
10.4 Middle East & Africa Recombinant Human Keratin Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific(Invitrogen)
11.1.1 Thermo Fisher Scientific(Invitrogen) Company Details
11.1.2 Thermo Fisher Scientific(Invitrogen) Business Overview
11.1.3 Thermo Fisher Scientific(Invitrogen) Recombinant Human Keratin Introduction
11.1.4 Thermo Fisher Scientific(Invitrogen) Revenue in Recombinant Human Keratin Business (2019-2024)
11.1.5 Thermo Fisher Scientific(Invitrogen) Recent Development
11.2 ABCAM
11.2.1 ABCAM Company Details
11.2.2 ABCAM Business Overview
11.2.3 ABCAM Recombinant Human Keratin Introduction
11.2.4 ABCAM Revenue in Recombinant Human Keratin Business (2019-2024)
11.2.5 ABCAM Recent Development
11.3 Novus Biologicals
11.3.1 Novus Biologicals Company Details
11.3.2 Novus Biologicals Business Overview
11.3.3 Novus Biologicals Recombinant Human Keratin Introduction
11.3.4 Novus Biologicals Revenue in Recombinant Human Keratin Business (2019-2024)
11.3.5 Novus Biologicals Recent Development
11.4 PROGEN
11.4.1 PROGEN Company Details
11.4.2 PROGEN Business Overview
11.4.3 PROGEN Recombinant Human Keratin Introduction
11.4.4 PROGEN Revenue in Recombinant Human Keratin Business (2019-2024)
11.4.5 PROGEN Recent Development
11.5 CUSABIO
11.5.1 CUSABIO Company Details
11.5.2 CUSABIO Business Overview
11.5.3 CUSABIO Recombinant Human Keratin Introduction
11.5.4 CUSABIO Revenue in Recombinant Human Keratin Business (2019-2024)
11.5.5 CUSABIO Recent Development
11.6 Prospec
11.6.1 Prospec Company Details
11.6.2 Prospec Business Overview
11.6.3 Prospec Recombinant Human Keratin Introduction
11.6.4 Prospec Revenue in Recombinant Human Keratin Business (2019-2024)
11.6.5 Prospec Recent Development
11.7 Biomatik
11.7.1 Biomatik Company Details
11.7.2 Biomatik Business Overview
11.7.3 Biomatik Recombinant Human Keratin Introduction
11.7.4 Biomatik Revenue in Recombinant Human Keratin Business (2019-2024)
11.7.5 Biomatik Recent Development
11.8 Creative Diagnostics
11.8.1 Creative Diagnostics Company Details
11.8.2 Creative Diagnostics Business Overview
11.8.3 Creative Diagnostics Recombinant Human Keratin Introduction
11.8.4 Creative Diagnostics Revenue in Recombinant Human Keratin Business (2019-2024)
11.8.5 Creative Diagnostics Recent Development
11.9 Signalway Antibody
11.9.1 Signalway Antibody Company Details
11.9.2 Signalway Antibody Business Overview
11.9.3 Signalway Antibody Recombinant Human Keratin Introduction
11.9.4 Signalway Antibody Revenue in Recombinant Human Keratin Business (2019-2024)
11.9.5 Signalway Antibody Recent Development
11.10 enQuire BioReagents
11.10.1 enQuire BioReagents Company Details
11.10.2 enQuire BioReagents Business Overview
11.10.3 enQuire BioReagents Recombinant Human Keratin Introduction
11.10.4 enQuire BioReagents Revenue in Recombinant Human Keratin Business (2019-2024)
11.10.5 enQuire BioReagents Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific(Invitrogen)
ABCAM
Novus Biologicals
PROGEN
CUSABIO
Prospec
Biomatik
Creative Diagnostics
Signalway Antibody
enQuire BioReagents

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂